investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Predicting Clinical Outcome After Traditional and Ibrutinib-based Therapy In Chronic Lymphocytic Leukemia
Tait D Shanafelt
5 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Curtis Hanson
Mayo Clinic (Rochester)
Rochester, United States
Braggio Esteban
Mayo Clinic (Rochester)
Rochester, United States
Alan Ramsay
King's College London
London, United Kingdom
Neil E Kay
Mayo Clinic (Rochester)
Rochester, United States
Xin Wang
Dana-Farber Cancer Institute
Boston, United States
University of Manchester
Manchester, United Kingdom
Tait D Shanafelt
Mayo Clinic (Rochester)
Rochester, United States
Related projects
Clark W Distelhorst
Bcl-2 Function on the Endoplasmic Reticulum
Leukaemia
Hematology and hematologic malignancies
Marc Nicklaus
In Silico Screening for Cancer Targets
Leukaemia
Hematology and hematologic malignancies
Peter Aplan
Collaborative Pathways that Lead to Leukemia – Rockville
Leukaemia
Hematology and hematologic malignancies
Elizaveta V Benevolenskaya
RBP2 Regulation Through Differential Recruitment to Genomic Loci
Leukaemia
Hematology and hematologic malignancies
Keisuke Ito
Epigenetic regulation by microRNA of MDS pathogenesis
Leukaemia
Hematology and hematologic malignancies
George Calin
Deciphering the Role of Non-coding RNA in Chronic Lymphocytic Leukemia
Leukaemia
Hematology and hematologic malignancies
Clark W Distelhorst
Targeting PKM2-InsP3R interaction to treat AML
Leukaemia
Hematology and hematologic malignancies
Catherine Ju-Ying Wu
(PQD1) Impact of Cytotoxic and Targeted Therapy on Clonal Evolution of CLL
Leukaemia
Hematology and hematologic malignancies
Tomasz Skorski
BCR/ABL-PI-3k-ROS pathway induce genomic instability ....
Leukaemia
Hematology and hematologic malignancies
